Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
NEKTAR THERAPEUTICS | SVP & Chief Commercial Officer | Common Stock | 223K | $109K | $0.49 | May 16, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NKTR | NEKTAR THERAPEUTICS | May 16, 2022 | 1 | -$18.1K | 4 | May 17, 2022 | SVP & Chief Commercial Officer |
NKTR | NEKTAR THERAPEUTICS | Feb 16, 2022 | 1 | -$53.1K | 4 | Feb 18, 2022 | SVP & Chief Commercial Officer |
NKTR | NEKTAR THERAPEUTICS | Dec 16, 2021 | 2 | $0 | 4 | Dec 20, 2021 | SVP & Chief Commercial Officer |
NKTR | NEKTAR THERAPEUTICS | Nov 16, 2021 | 1 | -$79.8K | 4 | Nov 17, 2021 | SVP & Chief Commercial Officer |
NKTR | NEKTAR THERAPEUTICS | Aug 16, 2021 | 1 | -$85.6K | 4 | Aug 18, 2021 | SVP & Chief Commercial Officer |
NKTR | NEKTAR THERAPEUTICS | May 17, 2021 | 1 | -$111K | 4 | May 19, 2021 | SVP & Chief Commercial Officer |